Muneer G. Hasham received his A.B from Bowdoin College and his Ph.D. from Temple University School of Medicine in Microbiology and Immunology. His thesis was on Cancer Virology. He joined The Jackson Laboratory as a post-doctoral fellow in 2003 using mouse models to find novel cures for various types of cancer, autoimmune and cardiac diseases. He remained as a post-doctoral fellow and then as a Research Scientist until 2021 when he became a Study Director, and then in 2023, an Associate Director for XLIS. He provides study design and regulatory expertise for pre-clinical and in vivo cell line and patient derived xenograft cancer growth, chemo- and immunotherapy efficacy studies, and live imaging systems. He has decades expertise in cellular assays and tissue culture propagation of cancer cell lines. In addition, Dr. Hasham has taught cancer genetics, courses on mouse models for cancer research and/or imaging systems for more than a decade via JAX Education. In his independent research, Dr. Hasham is focused on understanding the contribution of micro-environment genetics on cancer growth and response to chemo- or immunotherapy and novel drug delivery system.
